CN117567525A - Method for synthesizing N-glycoside by using unprotected sugar - Google Patents
Method for synthesizing N-glycoside by using unprotected sugar Download PDFInfo
- Publication number
- CN117567525A CN117567525A CN202311554074.5A CN202311554074A CN117567525A CN 117567525 A CN117567525 A CN 117567525A CN 202311554074 A CN202311554074 A CN 202311554074A CN 117567525 A CN117567525 A CN 117567525A
- Authority
- CN
- China
- Prior art keywords
- water
- reaction
- mmol
- dioxane
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- 235000000346 sugar Nutrition 0.000 title claims abstract description 23
- 229930182474 N-glycoside Natural products 0.000 title claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 102
- 238000006243 chemical reaction Methods 0.000 claims abstract description 91
- 239000000348 glycosyl donor Substances 0.000 claims abstract description 14
- 239000003513 alkali Substances 0.000 claims abstract description 10
- 239000012046 mixed solvent Substances 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 229930182470 glycoside Natural products 0.000 claims abstract description 4
- 150000002338 glycosides Chemical class 0.000 claims abstract description 3
- 239000000937 glycosyl acceptor Substances 0.000 claims abstract description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 113
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 66
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 claims description 36
- 239000003153 chemical reaction reagent Substances 0.000 claims description 27
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- -1 nitro, amino Chemical group 0.000 claims description 14
- 239000000370 acceptor Substances 0.000 claims description 13
- 229910021529 ammonia Inorganic materials 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- DURMTTFQKTWCRA-UHFFFAOYSA-N 2-formyloxy-2-hydroxyacetic acid Chemical compound OC(=O)C(O)OC=O DURMTTFQKTWCRA-UHFFFAOYSA-N 0.000 claims description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 4
- 150000004030 azacyclic compounds Chemical group 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 150000002016 disaccharides Chemical class 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 150000002243 furanoses Chemical class 0.000 claims description 4
- 125000002346 iodo group Chemical group I* 0.000 claims description 4
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 claims description 4
- 150000003214 pyranose derivatives Chemical group 0.000 claims description 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- CELWCAITJAEQNL-UHFFFAOYSA-N oxan-2-ol Chemical group OC1CCCCO1 CELWCAITJAEQNL-UHFFFAOYSA-N 0.000 claims description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 claims description 2
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 53
- 230000015572 biosynthetic process Effects 0.000 abstract description 49
- 238000006206 glycosylation reaction Methods 0.000 abstract description 13
- 230000013595 glycosylation Effects 0.000 abstract description 11
- 125000006239 protecting group Chemical group 0.000 abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 95
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 93
- 238000002360 preparation method Methods 0.000 description 36
- 238000004440 column chromatography Methods 0.000 description 32
- 238000001035 drying Methods 0.000 description 32
- 239000003480 eluent Substances 0.000 description 31
- 239000011541 reaction mixture Substances 0.000 description 27
- 229910052799 carbon Inorganic materials 0.000 description 23
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 21
- 238000012216 screening Methods 0.000 description 13
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 12
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 238000005406 washing Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical group ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 3
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 1
- ASQOQJYHIYYTEJ-GBESFXJTSA-N (1r,7s,9as)-7-decyl-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-1-ol Chemical compound O[C@@H]1CCCN2C[C@@H](CCCCCCCCCC)CC[C@H]21 ASQOQJYHIYYTEJ-GBESFXJTSA-N 0.000 description 1
- SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 description 1
- PHDIJLFSKNMCMI-ITGJKDDRSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol Chemical compound OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)OCCCCCCCCOC=1C=C2C=CC=NC2=CC=1)O PHDIJLFSKNMCMI-ITGJKDDRSA-N 0.000 description 1
- QKLXBIHSGMPUQS-FGZHOGPDSA-M (3r,5r)-7-[4-(4-fluorophenyl)-2,5-dimethyl-1-phenylpyrrol-3-yl]-3,5-dihydroxyheptanoate Chemical compound CC1=C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C=2C=CC(F)=CC=2)=C(C)N1C1=CC=CC=C1 QKLXBIHSGMPUQS-FGZHOGPDSA-M 0.000 description 1
- VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 1
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 1
- JNPGUXGVLNJQSQ-BGGMYYEUSA-M (e,3r,5s)-7-[4-(4-fluorophenyl)-1,2-di(propan-2-yl)pyrrol-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)N1C(C(C)C)=C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)C(C=2C=CC(F)=CC=2)=C1 JNPGUXGVLNJQSQ-BGGMYYEUSA-M 0.000 description 1
- VAVHMEQFYYBAPR-ITWZMISCSA-N (e,3r,5s)-7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid Chemical compound CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(C=2C=CC(F)=CC=2)=CN1C1=CC=CC=C1 VAVHMEQFYYBAPR-ITWZMISCSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- YMNPLUINBRDMEW-UHFFFAOYSA-N 2-butylpyrazolo[1,5-a]quinoxalin-4-amine Chemical compound CCCCc1cc2c(N)nc3ccccc3n2n1 YMNPLUINBRDMEW-UHFFFAOYSA-N 0.000 description 1
- BNGPVKSKKYIJCR-UHFFFAOYSA-N 2-chloro-1,3-dimethylimidazolidine;hydrochloride Chemical compound [Cl-].CN1CC[NH+](C)C1Cl BNGPVKSKKYIJCR-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 1
- AZMUHUYPUWGKJR-IWEFOYFVSA-N CC(C)C[C@@H](C(NN(C[C@H](CCN1)C1=O)C([C@H](F)Cl)=O)=O)NC(C(NC1=CC=C2)=CC1=C2F)=O Chemical compound CC(C)C[C@@H](C(NN(C[C@H](CCN1)C1=O)C([C@H](F)Cl)=O)=O)NC(C(NC1=CC=C2)=CC1=C2F)=O AZMUHUYPUWGKJR-IWEFOYFVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical group FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- BCVXHSPFUWZLGQ-UHFFFAOYSA-N mecn acetonitrile Chemical compound CC#N.CC#N BCVXHSPFUWZLGQ-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- JQSHBVHOMNKWFT-DTORHVGOSA-N varenicline Chemical compound C12=CC3=NC=CN=C3C=C2[C@H]2C[C@@H]1CNC2 JQSHBVHOMNKWFT-DTORHVGOSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
The invention relates to the technical field of chemical synthesis, in particular to a method for synthesizing N-glycoside by using unprotected sugar, which is characterized in that unprotected glycosyl donor, acceptor and alkali are dissolved in water or a mixed solvent of water and an organic solvent at the temperature of-78 ℃ to 25 ℃ and an accelerator is added for reaction to obtain corresponding glycoside. The method avoids complex operation of upper and lower protecting groups, has high stereoselectivity of products of glycosylation reaction, and greatly reduces complexity and synthesis cost of glycosylation synthesis operation.
Description
Technical Field
The invention relates to chemical synthesis, in particular to a method for synthesizing N-glycoside by using unprotected sugar.
Background
Sugars, also known as carbohydrates, are associated with proteins, nucleic acids and lipids and are known as four important classes of biological macromolecules during life activities. They are widely distributed in plants, animals, microorganisms and viruses. Saccharides are in the form of monosaccharides, oligosaccharides, polysaccharides and saccharide conjugates. Currently, there are two main methods for in vitro synthesis of sugar: enzymatic synthesis and chemical synthesis. Although enzymatic synthesis has the advantages of mild reaction, good regioselectivity and stereoselectivity, the required glycosyltransferases and glycosidases are relatively expensive, and in addition, the enzyme has poor acceptance of unnatural or abnormal substrates. Thus, chemical synthesis of sugar is indispensable. However, there are a number of drawbacks to the current glycosylation methods. To date, no glycosylation method has been generally applicable to the synthesis of all oligosaccharides. Furthermore, in the existing glycosylation synthesis, a large number of experimental operations involving the upper protecting group and deprotection group are involved, and the prolonged steps of the synthesis operation also increase the complexity of the synthesis. It is therefore of great interest to develop new unprotected sugars for one-pot glycosylation in the aqueous phase.
2-chloro-1, 3-dimethylimidazoline chloride (DMC), developed by Isobe and Ishikawathey in the late 1990's as a dehydration reagent capable of replacing DCC. In 2009, shoda et al introduced DMC for the first time into the carbohydrate domain and revealed its ability to selectively activate unprotected sugar anomeric hydroxyl groups in aqueous solution. Heretofore, DMC has been successfully applied to the synthesis of glycosyloxazolines, the production of 1, 6-anhydrous sugar, the synthesis of glycosylazides, glycosylthiols and the like, but no report has been made on N-glycoside.
Disclosure of Invention
Object of the Invention
In view of the above-mentioned deficiencies of the prior art, it is an object of the present invention to provide a method for the unprotected-sugar synthesis of N-glycosylation mediated by DMC and its analogues.
Technical proposal
A method for synthesizing N-glycoside by using unprotected sugar is characterized in that unprotected glycosyl donor, acceptor and alkali are dissolved in water or a mixed solvent of water and an organic solvent at the temperature of-78 ℃ to 25 ℃, and an accelerator is added to react to obtain the corresponding glycoside, and the reaction general formula is as follows:
the glycosyl donor is pyranose, furanose, disaccharide, polysaccharide or sugar structural analogue;
the receptor is an azacyclic compound or organic ammonia;
the base is triethylamine or DIPEA;
the accelerator is selected from any one of the following structures:
the method is characterized in that,
pyranose is ribose, arabinose or 2-deoxyribose;
the furanose is glucose, galactose, mannose, fucose, xylose, arabinose, N-acetamido glucose or rhamnose;
disaccharides are lactose, maltose or cellobiose;
the sugar structural analogue is tetrahydro-2H-pyran-2-ol.
The method is characterized in that when the receptor is an azacyclic compound, the receptor is selected from any of the following compounds:
wherein R is 1 Is hydrogen, fluorine, chlorine, bromine, iodine, amino, acetoacetyl, azobenzoyl, NHBoc or N (Boc) 2 ;R 2 In the hydrogen, fluorine, chlorine, bromine, iodine, amino, acetoacetyl, azobenzoyl, NHBoc or N (Boc) 2 ;R 3 Hydrogen, hydroxy, carboxy, methyl formate, nitro, amino, fluoro, chloro, bromo or iodo; r is R 4 Hydrogen, hydroxy, carboxy, methyl formate, nitro, amino, fluoro, chloro, bromo or iodo;
when the acceptor is organic ammonia, the acceptor comprises straight-chain ammonia and aromatic ammonia, wherein the straight-chain ammonia is n-butylamine, and the aromatic ammonia is aniline, p-methylaniline or p-methoxyaniline.
The method is characterized in that the mixed solvent of water and an organic solvent is any one of mixed reagent of water and tetrahydrofuran, mixed reagent of water and 1, 4-dioxane, mixed reagent of water and acetonitrile, mixed reagent of water and DMF, mixed reagent of water and DMSO and mixed reagent of water and acetone.
The method is characterized in that:
the molar ratio of the glycosyl donor to the acceptor is 1:1.1-1:10; the molar ratio of the glycosyl donor to the accelerator is 1:1.5-1:5; the molar ratio of the glycosyl donor to the alkali is 1:5-1:20.
The method is characterized in that: the volume ratio of the mixed solvent of the reaction solvents is 1:0-1:5.
The method is characterized in that: the temperature is-10 ℃.
In some embodiments of the invention, the molar ratio of glycosyl donor to acceptor is 1:1.1 to 1:10, preferably 1:5; the molar ratio of the glycosyl donor to the accelerator is 1:1.5-1:5, preferably 1:3; the molar ratio of the glycosyl donor to the alkali is 1:5-1:20, preferably 1:5-1:10, and most preferably 1:10;
in some embodiments of the present invention, the reaction solvent is any one of water, a mixed reagent of water and tetrahydrofuran, a mixed reagent of water and 1, 4-dioxane, a mixed reagent of water and acetonitrile, a mixed reagent of water and DMF, a mixed reagent of water and DMSO, a mixed reagent of water and acetone, preferably a mixed reagent of water and tetrahydrofuran or a mixed reagent of water and 1, 4-dioxane.
In some embodiments of the present invention, the mixing ratio (volume ratio) of the reaction solvent is preferably V Water and its preparation method :V Organic reagent =1:0 to 1:1, most preferably V Water and its preparation method :V Organic reagent =1:1;
In some embodiments of the invention, the aqueous phase glycosylation product is subjected to an acetylation step, in view of the ease of subsequent isolation and purification and structural rigidity, characterized in that: dissolving the aqueous phase glycosylation product in anhydrous pyridine at 0 ℃, slowly adding acetic anhydride, reacting overnight at room temperature, washing the reaction liquid with 1N diluted hydrochloric acid, extracting the reaction liquid with EA for three times, combining organic phases, washing the organic phases with water, washing with saturated sodium bicarbonate, washing with brine, drying with anhydrous sodium sulfate, filtering, and purifying by column chromatography.
Further, the molar ratio of the aqueous phase glycosylation product to pyridine is 1:5-1: 30, preferably 1:10; the molar ratio of the aqueous phase glycosylation product to acetic anhydride is 1:4 to 1:20, preferably 1:5.
The following steps were used for screening for further inventors:
1. screening for alkali
Wherein the sugar is D-glucose, the acceptor is 6-chloropurine, the promoter is 1-1, the solvent is water and 1, 4-dioxane (V) Water and its preparation method :V Organic reagent For example, =1:1) and at-10 ℃, common bases were screened for the following reaction formula:
the alkali type screening results are shown in Table 1.
TABLE 1 alkali species screening
Note that: trace is a yield of less than 5%.
2. Screening the promoter
With sugar as D-glucose, 6-chloropurine as acceptor, triethylamine as base, water and 1, 4-dioxane (V) as reaction solvent at-10deg.C Water and its preparation method :V Organic reagent For example, =1:1), the accelerators were screened and the reaction formula was as follows:
the screening results are shown in Table 2.
TABLE 2 promoter screening
3. Screening the solvent and the solvent proportion
Taking D-glucose as sugar, 6-chloropurine as acceptor, 1-1 as promoter, triethylamine as base and-10deg.C as examples, selecting solvent and solvent ratio, and reacting with the following formula:
the screening results are shown in Table 3.
TABLE 3 solvent screening
4. Screening the conditions of the reaction temperature
In some embodiments of the invention, the temperature is from-78 ℃ to 25 ℃, preferably from-40 ℃ to-10 ℃, most preferably-10 ℃. Sugar is D-glucose, acceptor is 6-chloropurine, accelerator is compound 1-1, base is triethylamine, and solvent is water and 1, 4-dioxane (V) Water and its preparation method :V Organic reagent For example, =1:1), the conditions were selected for the reaction temperature, and the reaction formula was as follows:
the screening results are shown in Table 4.
TABLE 4 temperature screening
The beneficial effects are that:
1. the prior art shows that DMC has been successfully applied to the synthesis of glycosyloxazolines, the production of 1, 6-anhydrous sugar, the synthesis of glycosylazides, glycosylthiols and the like, but no literature report of N-glycoside is seen, and particularly the receptor is a nucleotide base. For example, receptors such as purines, where there are multiple sites N, but specific binding to a particular site such as position 9, without the need for protecting groups, is a constant technical difficulty in the art. The invention discovers that DMC can mediate the synthesis of N-glycoside (nucleotide) by unprotected sugar under specific conditions of temperature and alkali for the first time, wherein attention is required to be paid to the fact that N at 9-position of a receptor can be selectively bound instead of N at other positions, and the above-mentioned non-literature report is provided.
2. The invention synthesizes a series of analogues of DMC, which are not reported in literature, belong to novel compounds, can mediate unprotected glycosylation of receptor as base, and can specifically bind to 9-position N of receptor. The method avoids complex operation of upper and lower protecting groups, has high stereoselectivity of products of glycosylation reaction, and greatly reduces complexity and synthesis cost of glycosylation synthesis operation.
Abbreviation form
Boc | Boc-group |
Bz | Benzoyl group |
Ac | Acetyl group |
DCM | Dichloromethane (dichloromethane) |
PE | Petroleum ether |
EA | Acetic acid ethyl ester |
THF | Tetrahydrofuran (THF) |
DMF | N, N-dimethylformamide |
DMSO | Dimethyl sulfoxide |
Dioxane | 1, 4-Dioxahexacyclic ring |
MeOH | Methanol |
DBU | 1, 8-diazabicyclo [5.4.0]Undec-7-ene |
DIPEA | Diisopropylethylamine |
DABCO | Triethylene diamine |
TEA | Triethylamine |
DMC | 2-chloro-1, 3-dimethylchlorinated imidazolines |
CDMBI | 2-chloro-1, 3-dimethyl-1H-benzimidazole-3-chloride |
NaOH | Sodium hydroxide |
R.T. | Room temperature |
MeCN | Acetonitrile |
Terminology and description
In the present invention, unless otherwise indicated, scientific and technical terms used herein have the meanings commonly understood by one of ordinary skill in the art. Meanwhile, in order to better understand the present invention, definitions and explanations of related terms are provided below.
All ranges recited herein include those endpoints that list ranges between the two values. All values recited herein, whether or not stated, include the degree of expected experimental error, technical error, and instrumental error for a given technique for measuring the value.
In the present invention,% is weight/weight (w/w) percent unless otherwise indicated.
In the present invention, room temperature is 20 to 30 ℃, for example: 20 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 ℃.
Unless otherwise indicated, any numerical values, such as concentrations or ranges of concentrations described herein, are to be understood as being modified in all instances by the term "about. Thus, a numerical value typically includes ±10% of the value.
"alkyl" refers to saturated aliphatic hydrocarbon groups, straight and branched chain groups comprising 1 to 10 carbon atoms, preferably comprising 1 to 6 carbon atoms. Non-limiting examples of alkyl groups in the present invention include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 2-dimethylpropyl, 1-ethylpropyl, 2-methylbutyl, 3-methylbutyl, n-hexyl, 1-ethyl-2-methylpropyl, 1, 2-trimethylpropyl, 1-dimethylbutyl, 1, 2-dimethylbutyl, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2-ethylbutyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 2, 3-dimethylbutyl, and the like. The alkyl groups may be substituted or unsubstituted, and when substituted, the substituents may be substituted at any useful point of attachment, preferably one or more groups independently selected from alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylamino, halogen, thiol, hydroxy, nitro, cyano, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkoxy, heterocycloalkoxy, cycloalkylthio, heterocycloalkylthio, oxo. In some preferred embodiments of the invention, alkyl is methyl or ethyl.
Drawings
FIG. 1 is a nuclear magnetic resonance spectrum of the compound 1aa obtained in example 1.
Detailed Description
The invention will now be described in further detail with reference to the following examples, it being understood that the following description is illustrative only and is not limiting in any way. The experimental methods in the following examples are conventional methods unless otherwise specified. The test materials used in the examples described below, unless otherwise specified, were purchased from conventional biochemical reagent stores.
Example 1:
synthesis of 1 a:
d-glucose(45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixture of water and 1, 4-dioxane (1 ml, V total) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 58% yield.
Example 2:
synthesis of 1 aa:
dissolving 1a in anhydrous pyridine at 0 ℃, slowly adding acetic anhydride, reacting overnight at room temperature, washing the reaction liquid with 1N diluted hydrochloric acid, performing EA extraction reaction for three times, combining organic phases, washing the organic phases with water, washing with saturated sodium bicarbonate, washing with brine, drying with anhydrous sodium sulfate, and purifying by column chromatography. The nuclear magnetic spectrum is shown as S1, and is consistent with the result of the spectrum in the existing report.
1 H NMR(300MHz,Chloroform-d)δ8.78(s,1H),8.34(s,1H),5.96(d,J=9.5Hz,1H),5.68(t,J=9.4Hz,1H),5.48(t,J=9.4Hz,1H),5.31(t,J=9.7Hz,1H),4.30(dd,J=12.6,4.8Hz,1H),4.19–4.00(m,2H),2.08(s,3H),2.07(s,3H),2.04(s,3H),1.78(s,3H).
Example 3:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and CDMBI (165 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction solution is dried by spinning, and purified by column chromatography (the eluent adopts ethyl acetate: methanol=10:1) to obtain the targeted productCompound 1a, 49% yield.
Example 4:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-4 (127.5 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 17% yield.
Example 5:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-5 (137.6 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 30% yield.
Example 6:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-6 (167.3 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane =1:1), pre-cooled triethylamine 350ul is added at-10 ℃, and reaction is carried out for 5min at-10 ℃ and then6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 32% yield.
Example 7:
/>
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-7 (188.2 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 32% yield.
Example 8:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-8 (240.8 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 37% yield.
Example 9:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-9 (208.9 mg,0.75 mmol) were dissolvedIn a mixed system of water and 1, 4-dioxane (1 ml, V in total) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 50% yield.
Example 10:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-10 (165.2 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 43% yield.
Example 11:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-11 (183.9 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 50% yield.
Example 12:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-12 (245.0 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was maintained at-10 ℃ overnight, the aqueous layer was extracted with DCM, the aqueous layer was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the title compound 1a in 40% yield.
Example 13:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and 1-13 (204.7 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was maintained at-10 ℃ overnight, the aqueous layer was extracted with DCM, the aqueous layer was dried by spin-drying, and purified by column chromatography (eluent ethyl acetate: methanol=10:1) to give the title compound 1a in 39% yield.
Example 14:
synthesis of 1 a:
d-glucose (45 mg,0.25 mmol) and DMC (127 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (1 ml total, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1a in 47 yield%。
Example 15:
/>
1b synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-2-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1b in 29% yield.
Example 16:
1c synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, para-6-methoxypurine (187.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1c in 46% yield.
Example 17:
1d synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane =1:1), pre-cooled triethylamine 350ul was added at-10 ℃, and p-purine (15) was added after reaction at-10 ℃ for 5min0.4mg,1.25 mmol). The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1d in 36% yield.
Example 18:
1e synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ in =1:1), 350ul of pre-cooled triethylamine was added, and after 5min of reaction at-10 ℃, pair 1-18 (262.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 1e in 35% yield.
Example 19:
1f synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ in =1:1), 350ul of pre-cooled triethylamine was added, and after 5min of reaction at-10 ℃, pair 1-19 (337 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=20:1 as eluent) to give the objective compound 1f in 56% yield.
Example 20:
synthesis of 1 g:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixture of water and 1, 4-dioxaneSystemium (1 ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-bromopurine (248.7 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give 1g of the objective compound in 45% yield.
Example 21:
synthesizing for 1 h:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, para-6-methylpurine (167.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound in 48% yield for 1 h.
Example 22:
2a synthesis:
d-mannose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 2a in 40% yield.
Example 23:
/>
2b synthesis:
d-mannose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-bromopurine (248.7 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 2b in 35% yield.
Example 24:
2c synthesis:
d-mannose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ in =1:1), 350ul of pre-cooled triethylamine was added, and after 5min of reaction at-10 ℃, pair 1-24 (418.8 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=20:1 as eluent) to give the objective compound 2c in 31% yield.
Example 25:
synthesis of 3 a:
d-xylose (38 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 3a in 31% yield.
Example 26
4a synthesis:
l-rhamnose (41 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (1 ml total, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 4a in 27% yield.
Example 27:
synthesis of 5 a:
d-galactose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-bromopurine (248.7 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 5a in 26% yield.
Example 28:
6a synthesis:
cellobiose (85.5 mg,0.25 mmol) and 1-1 (308.2 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, spin-drying the reaction solutionColumn chromatography purification (eluent ethyl acetate: methanol=8:1) afforded the title compound 6a in 29% yield.
Example 29
7a synthesis:
lactose (85.5 mg,0.25 mmol) and 1-1 (308.2 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=8:1 as eluent) to give the objective compound 7a in 30% yield.
Example 29
8a synthesis:
n-acetylglucosamine (55 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and after 5min of reaction at-10 ℃, p-6-chloropurine (192.5 mg,1.25 mmol) was added. The reaction was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 8a in 42% yield.
Example 31:
9a synthesis:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and tetrahydrofuran (total 1ml, V) Water and its preparation method :V THF =1:1), -10350ul of pre-cooled triethylamine was added at-10℃and after 5min of reaction, n-butylamine (91.2 mg,1.25 mmol) was added. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 9a in 36% yield.
Example 32:
synthesis of 10 a:
d-glucose (45 mg,0.25 mmol) and 1-1 (228 mg,0.75 mmol) were dissolved in a mixed system of water and 1, 4-dioxane (total 1ml, V) Water and its preparation method :V Dioxane To-10 ℃ was added 350ul of pre-cooled triethylamine, and p-aniline (116.4 mg,1.25 mmol) was added after reaction at-10 ℃ for 30 min. The temperature was kept at-10℃and monitored by TLC. After the reaction, the reaction mixture was dried by spin-drying, and purified by column chromatography (ethyl acetate: methanol=10:1 as eluent) to give the objective compound 10a (β: α=3:1) in 78% yield.
Reference is made to:
[1]Tanaka T,Nagai H,Noguchi M,et al.One-step conversion of unprotected sugars to b-glycosyl azides using 2-chloroimidazolinium salt in aqueous solution[J].Chemical communications-royal society of chemistry,2009(23):3378;
[2]Tomonari,Tanaka,Takeshi,et al.Direct Transformation of Unprotected Sugars to Aryl1-Thio-β-glycosides in Aqueous Media Using 2-Chloro-1,3-dimethylimidazolinium Chloride[J].Chemistry Letters,2009,38(5):458-459;
[3]M.Sc,Sebastian,et al.One-Pot Synthesis of Unprotected Anomeric Glycosyl Thiols in Water for Glycan Ligation Reactions with Highly Functionalized Sugars[J].
Angewandte Chemie International Edition,2016;[4]Qiu X,Fairbanks AJ.Direct Synthesis of para-Nitrophenyl Glycosides from Reducing Sugars in Water[J].Organic Letters,2020,22(6).
Claims (7)
1. a method for synthesizing N-glycoside by using unprotected sugar is characterized in that unprotected glycosyl donor, acceptor and alkali are dissolved in water or a mixed solvent of water and an organic solvent at the temperature of-78 ℃ to 25 ℃, and an accelerator is added to react to obtain the corresponding glycoside, and the reaction general formula is as follows:
wherein: r is a structure corresponding to a receptor;
the glycosyl donor is pyranose, furanose, disaccharide, polysaccharide or sugar structural analogue;
the receptor is an azacyclic compound or organic ammonia;
the base is triethylamine or DIPEA;
the accelerator is selected from any one of the following structures:
2. the method of claim 1, wherein the step of determining the position of the substrate comprises,
pyranose is ribose, arabinose or 2-deoxyribose;
the furanose is glucose, galactose, mannose, fucose, xylose, arabinose, N-acetamido glucose or rhamnose;
disaccharides are lactose, maltose or cellobiose;
the sugar structural analogue is tetrahydro-2H-pyran-2-ol.
3. The method of claim 1, wherein when the acceptor is an azacyclic compound, the acceptor is selected from any of the structural compounds shown below:
wherein R is 1 Is hydrogen, fluorine, chlorine, bromine, iodine, amino, acetoacetyl, azobenzoyl, NHBoc or N (Boc) 2; R 2 In the hydrogen, fluorine, chlorine, bromine, iodine, amino, acetoacetyl, azobenzoyl, NHBoc or N (Boc) 2; R 3 Hydrogen, hydroxy, carboxy, methyl formate, nitro, amino, fluoro, chloro, bromo or iodo; r is R 4 Hydrogen, hydroxy, carboxy, methyl formate, nitro, amino, fluoro, chloro, bromo or iodo;
when the acceptor is organic ammonia, the acceptor comprises linear ammonia and aromatic ammonia, wherein the linear ammonia is n-butylamine, and the aromatic ammonia is aniline, p-methylaniline or p-methoxyaniline.
4. The method according to claim 1, wherein the mixed solvent of water and an organic solvent is any one of a mixed reagent of water and tetrahydrofuran, a mixed reagent of water and 1, 4-dioxane, a mixed reagent of water and acetonitrile, a mixed reagent of water and DMF, a mixed reagent of water and DMSO, and a mixed reagent of water and acetone.
5. The method according to claim 4, wherein: the volume ratio of the mixed solvent of the reaction solvents is 1:0-1:5.
6. The method according to claim 1, characterized in that:
the molar ratio of the glycosyl donor to the acceptor is 1:1.1-1:10; the molar ratio of the glycosyl donor to the accelerator is 1:1.5-1:5; the molar ratio of the glycosyl donor to the alkali is 1:5-1:20.
7. The method according to claim 1, characterized in that: the temperature is-10 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311554074.5A CN117567525A (en) | 2023-11-21 | 2023-11-21 | Method for synthesizing N-glycoside by using unprotected sugar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311554074.5A CN117567525A (en) | 2023-11-21 | 2023-11-21 | Method for synthesizing N-glycoside by using unprotected sugar |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117567525A true CN117567525A (en) | 2024-02-20 |
Family
ID=89862059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311554074.5A Pending CN117567525A (en) | 2023-11-21 | 2023-11-21 | Method for synthesizing N-glycoside by using unprotected sugar |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117567525A (en) |
-
2023
- 2023-11-21 CN CN202311554074.5A patent/CN117567525A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Herzig et al. | Studies in sugar chemistry. 2. A simple method for O-deacylation of polyacylated sugars | |
EP2318423B1 (en) | Process for making 5-azacytosine nucleosides and their derivatives | |
De Meo et al. | Chemical synthesis of glycosides of N-acetylneuraminic acid | |
US5998595A (en) | Azidohalogenobenzyl derivatives, sugar compounds and protection of hydroxy groups | |
Shi et al. | Fe2 (SO4) 3· xH2O-catalyzed per-O-acetylation of sugars compatible with acid-labile protecting groups adopted in carbohydrate chemistry | |
Kováč et al. | Synthesis and characterization of methyl 6-O-α-and-β-d-galactopyranosyl-β-d-galactopyranoside | |
Shaikh et al. | Ultrasonic assisted Fischer glycosylation: generating diversity for glycochemistry | |
Kováč et al. | Synthesis of methyl O-(3-deoxy-3-fluoro-β-d-galactopyranosyl)-(1→ 6)-β-d-galactopyranoside and methyl O-(3-deoxy-3-fluoro-β-d-galactopyranosyl)-(1→ 6)-O-β-d-galactopyranosyl-(1→ 6)-β-d-galactopyranoside | |
Matsuo et al. | Stereoselective synthesis of β-glycosyl esters of cis-cinnamic acid and its derivatives using unprotected glycosyl donors | |
US7772381B2 (en) | Efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (α-PGG) and its analogues | |
EP1144430A1 (en) | Protecting groups for carbohydrate synthesis | |
CN117567525A (en) | Method for synthesizing N-glycoside by using unprotected sugar | |
Hermans et al. | Benzyl-2, 4-Diacetamido-2, 4, 6-Tri-Deoxy-α (β)-D-Galactopyranoside | |
Winterfeld et al. | Convenient Synthesis of Nucleosides of 2‐Deoxy‐2‐nitro‐d‐galactose andN‐Acetyl‐d‐galactosamine | |
Jamoisa et al. | How to improve chemical synthesis of laminaribiose on a large scale | |
Matsunami et al. | Chemical modification of the nonreducing, terminal group of maltotriose | |
Liang et al. | TsOH-catalyzed acyl migration reaction of the Bz-group: innovative assembly of various building blocks for the synthesis of saccharides | |
Napoli et al. | Synthetic studies on the glycosylation of the base residues of inosine and uridine | |
CA2015074A1 (en) | Process for the preparation of etoposides | |
Kuszmann et al. | Two approaches to the synthesis of 3-β-d-glucopyranosyl-d-glucitol | |
JP5004950B2 (en) | Production of polysaccharides containing L-iduronate | |
Ferry et al. | Recent advances in the functionalization of unprotected carbohydrates | |
CN112209977B (en) | Decitabine intermediate compound VI | |
JP3837876B2 (en) | Azidohalogenobenzyl derivatives and methods for protecting hydroxyl groups | |
CN115505017A (en) | Synthesis method of etoposide and analogues thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |